Another study reported the inhibition of cell proliferation and migration in oral cancer cells (H400 and H357) by EGCG treatment through reduced expression of phosphorylated epidermal growth factor receptor (EGFR) [70]. This evidence concerns the gene EGFR and lip and oral cavity carcinoma.